Leerink: Pharmacyclics Is Now Worth $240

By: via Benzinga
In a report published Monday, Leerink analysts Howard Liang and Gena Wang boosted their price target on Pharmacyclics, Inc. (NASDAQ: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.